Clin2
NCT06993181Likely a fitNot yet recruiting

Testing a new study drug in healthy adults

Healthy

This trial tests a new study drug (DA-5222) given alone or with three other components in healthy adults. It helps researchers understand how the drug works in the body and check for any side effects.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
48 people
Ages
19 years and older
Study type
Interventional

Who can take part

  • You are generally healthy without chronic medical conditions.
  • Your body mass index (BMI) is between 18 and 30.
  • Your weight is at least 110 pounds (50 kg) for men or 99 pounds (45 kg) for women.
  • You have no history of drug abuse or addiction.
  • You have no known allergies or drug hypersensitivity.
  • You are willing to sign a consent form after understanding the study details.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06616883Not yet recruiting· Phase 1
Study of a new drug in healthy adults

This trial tests how a new drug (DA-5221) works in the body and whether it is safe for healthy adults. If you join, you'll help researchers understand how to dose this medicine for future patients.

Seoul, South Korea
NCT06993168Not yet recruiting· Phase 1
Food effect trial for an investigational drug in healthy adults

This trial tests how food affects the absorption of a new drug called DA-5222 in healthy adults. You may participate if you are generally healthy and have a normal body weight.

Seoul, South Korea
NCT06577337Recruiting· Phase 1
Testing a new drug (M5542) in healthy volunteers

This early-phase study tests a new experimental drug (M5542) in healthy volunteers to see how safe it is and how the body processes a single dose. If you are in good health and meet simple weight and medical history criteria, you may be able to join.

Neu-Ulm
NCT07232121Recruiting· Phase 1
Safety study of DF5112 in healthy adults

This study tests a new drug called DF5112 in healthy adults to find the safest dose. It helps doctors learn how the drug works in the body before testing it in people with a condition.

Sydney, New South Wales
NCT07235163Recruiting· Phase 1
Testing a new medicine in healthy adults

This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.

Brussels, Bruxelles-capitale, Région de
NCT07677163Recruiting· Phase 1
Testing a study drug in healthy adults

This is an early-phase study testing a new drug called MK-1403 in healthy people. It helps doctors learn how the drug works in the body and if it is safe.

Miami, Florida

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.